CVE-2016-0555
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2...
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2, 12.1.1, 12.1.2, and 12.1.3 allows remote attackers to affect integrity via unknown vectors related to Studio.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2, 12.1.1, 12.1.2, and 12.1.3 allows remote attackers to affect integrity via unknown vectors related to Studio.
- Record
CVE-2016-0555- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2, 12.1.1, 12.1.2, and 12.1.3 allows remote attackers to affect integrity via unknown vectors related to Studio.
- Record
CVE-2016-0555- Updated
- 2026-11-02
EUVDEUVD-2016-0590 No score
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2, 12.1.1, 12.1.2, and 12.1.3 allows remote attackers to affect integrity via unknown vectors related to Studio.
- Record
EUVD-2016-0590- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-99wq-2gq2-hq63 No score
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2...
Unspecified vulnerability in the Oracle CADView-3D component in Oracle E-Business Suite 11.5.10.2, 12.1.1, 12.1.2, and 12.1.3 allows remote attackers to affect integrity via unknown vectors related to Studio.
- Record
GHSA-99wq-2gq2-hq63- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2016-0555 is a medium vulnerability (CVSS 4.3) in Oracle Cadview-3d, published January 21, 2016. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.45%, the 73rd percentile. No source names a fixed version.